3aj5: Revision history

1 November 2023

• curprev 17:2817:28, 1 November 2023‎ OCA talk contribs‎ 4,702 bytes +575‎ No edit summary

4 May 2022

• curprev 16:2516:25, 4 May 2022‎ OCA talk contribs‎ 4,127 bytes +60‎ No edit summary

29 July 2020

• curprev 15:2215:22, 29 July 2020‎ OCA talk contribs‎ 4,067 bytes +49‎ No edit summary

4 August 2016

• curprev 22:4522:45, 4 August 2016‎ OCA talk contribs‎ 4,018 bytes +217‎ No edit summary

24 December 2014

• curprev 21:5521:55, 24 December 2014‎ OCA talk contribs‎ 3,801 bytes +339‎ No edit summary

17 December 2014

• curprev 16:5816:58, 17 December 2014‎ OCA talk contribs‎ 3,462 bytes +2,599‎ No edit summary

11 March 2013

• curprev 13:3313:33, 11 March 2013‎ OCA talk contribs‎ 863 bytes −33‎ No edit summary

20 October 2012

• curprev 11:0911:09, 20 October 2012‎ OCA talk contribs‎ 896 bytes −21‎ No edit summary

25 July 2012

• curprev 21:3721:37, 25 July 2012‎ OCA talk contribs‎ 917 bytes −535‎ No edit summary

27 July 2011

• curprev 07:5807:58, 27 July 2011‎ OCA talk contribs‎ 1,452 bytes +167‎ No edit summary

1 June 2011

• curprev 08:5008:50, 1 June 2011‎ OCA talk contribs‎ m 1,285 bytes 0‎ Protected "3aj5" [edit=sysop:move=sysop]
• curprev 08:5008:50, 1 June 2011‎ OCA talk contribs‎ 1,285 bytes +919‎ No edit summary

16 June 2010

• curprev 07:2207:22, 16 June 2010‎ OCA talk contribs‎ 366 bytes +24‎ No edit summary

2 June 2010

• curprev 07:2207:22, 2 June 2010‎ OCA talk contribs‎ 342 bytes +342‎ New page: '''Unreleased structure''' The entry 3aj5 is ON HOLD Authors: Nakamura, T., Tonozuka, T., Sato, R., Oguma, K., Nishikawa, A. Description: HA1 (HA33) subcomponent of botulinum type C pr...